These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12218465)

  • 21. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitrectomy in eyes with unsuspected retinoblastoma.
    Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
    Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoreduction in the initial management of intraocular retinoblastoma.
    Shields CL; De Potter P; Himelstein BP; Shields JA; Meadows AT; Maris JM
    Arch Ophthalmol; 1996 Nov; 114(11):1330-8. PubMed ID: 8906023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retinoblastoma update--therapy (Part II)].
    Pogrzebielski A; Shields CL; Romanowska-Dixon B; Shields JA
    Klin Oczna; 2006; 108(4-6):258-62. PubMed ID: 17020008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
    Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
    Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoreduction in the management of retinoblastoma.
    Shields JA; Shields CL; Meadows AT
    Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
    [No Abstract]   [Full Text] [Related]  

  • 29. Forget-me-nots in the care of children with retinoblastoma.
    Shields CL
    Semin Ophthalmol; 2008; 23(5):324-34. PubMed ID: 19085435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative treatments of intraocular retinoblastoma.
    Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
    Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreoretinal complications of retinoblastoma treatment.
    Tawansy KA; Samuel MA; Shammas M; Murphree AL
    Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
    Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors.
    Shields CL; Shields JA; Cater J; Othmane I; Singh AD; Micaily B
    Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J; Piwowarczyk A; Romanowska-Dixon B; Balwierz W; Dłuzniewska A
    Klin Oczna; 2006; 108(1-3):55-9. PubMed ID: 16883942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
    Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.